8th Nov 2006 10:04
Sinclair Pharma PLC08 November 2006 Sinclair Pharma plc presenting at Rodman & Renshaw 8th Annual Global Healthcare Conference 8 November 2006, London, UK - Sinclair Pharma plc (AIM: SPH.L), theinternational specialty pharmaceutical company today announces that its ChiefExecutive Officer, Dr Michael Flynn, and Chief Financial Officer Jerry Randall,will be presenting at the Rodman & Renshaw 8th Annual Global HealthcareConference in New York on Wednesday 8 November at 4.30pm. The presentation can be found at Sinclair's website, at the following page:http://www.sinclairpharma.com/news_reports.php Sinclair Pharma plc Sinclair Pharma plc is an international specialty pharmaceutical company. Ithas a growing sales and marketing operation that is already present in France,Italy, the UK, Spain and Portugal, and a complementary marketing partner networkthat spans 60 countries. Sinclair has proven expertise in acquiring or developing commercially attractiveand undervalued products, registering these products and bringing them to marketwithin a short time frame. The company focuses on niche therapeutic areas andits current portfolio includes products for dermatological conditions and oralhealth. Enquiries: Financial Dynamics Tel: +44 20 7831 3113 Ben Atwell/John Gilbert Sinclair Pharma plc Tel: +44 1483 410 600 Zoe McDougall Tel: +44 7973 792 520 John Barrington-Carver +44 7831 655 630 Sinclair US Tel +1 972 478 4380 Mike Killeen This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma